Thirty-six female SPF Sprague-Dawley rats (10-weeks-old, weighing 220–250 g, purchased from Shanghai Bikai-Keyi Biotechnology Co., Ltd., China) were acclimated for one week post-arrival before experiments were performed. Rats were housed in a constant temperature environment (22 ± 2 °C) with a humidity of 50%–60%, ad libitum access to food and water, and a light/dark cycle of 12/12 h.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by James ND
Surgery, radiotherapy and endocrine therapy for oligometastatic prostate cancer efficacy: a systematic review and network meta-analysis
Oligometastatic prostate cancer (omPCa) represents an intermediate stage of cancer dissemination between localized and widely metastatic disease. With dramatic improvements in staging—particularly through advanced functional imaging such as PSMA-PET and robotic-assisted (RA) targeted biopsies (RA-TB)—omPCa is now more frequently detected, both at primary diagnosis and in oligorecurrent disease (Patel et al., 2020). Singh et al.
Prognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer: a systematic review and meta-analysis
Prognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer: a systematic review and meta-analysis 1Department of Urology, Baoding No.1 Central Hospital, Baoding, Hebei, China 2Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province, Baoding, Hebei, China 3Prostate and Andrology Key Laboratory of Baoding, Baoding, Hebei, China 4Department of Urology, Heze Municipal Hospital, Heze, Shandong, China 5Psychosomatic Medical Center, The Fourth...
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of prostate cancer: a retrospective study
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and risk of prostate cancer: a retrospective study 1School of Public Health, Xinjiang Medical University, Urumqi, Xinjiang Uighur Autonomous Region, China 2Research Management Section, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang Uighur Autonomous Region, China 3Urology Department, The First Affiliated Hospital of Xinjiang Medical University,...
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 - PubMed
Background: Innovations in imaging and molecular characterisation together with novel treatment options have improved outcomes in advanced prostate cancer. However, we still lack high-level evidence in many areas relevant to making management decisions in daily clinical practise. The 2022 Advanced Prostate Cancer Consensus Conference (APCCC 2022) addressed some questions in these areas to supplement guidelines that mostly are based on level 1 evidence.
Zoledronic acid reduces skeletal complications for men with progressive bony prostate cancer
The addition of zoledronic acid to docetaxel significantly reduced the rate of skeletal-related events but did not prolong OS or clinical PFS among men with metastatic castrate-refractory prostate cancer, according to results of the TRAPEZE study. Further, the addition of strontium-89 to docetaxel appeared to improve clinical PFS but had no effect on OS or skeletal-related events, results showed.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with James
Contact James, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack